Published in J Neurotrauma on February 06, 2014
IL-1β associations with posttraumatic epilepsy development: a genetics and biomarker cohort study. Epilepsia (2014) 2.59
Variable neuroendocrine-immune dysfunction in individuals with unfavorable outcome after severe traumatic brain injury. Brain Behav Immun (2014) 0.95
Embracing failure: What the Phase III progesterone studies can teach about TBI clinical trials. Brain Inj (2015) 0.91
Progesterone for neuroprotection in pediatric traumatic brain injury. Pediatr Crit Care Med (2015) 0.82
Brain-Derived Neurotrophic Factor (BDNF) in Traumatic Brain Injury-Related Mortality: Interrelationships Between Genetics and Acute Systemic and Central Nervous System BDNF Profiles. Neurorehabil Neural Repair (2015) 0.82
Cortisol-induced immune suppression by a blockade of lymphocyte egress in traumatic brain injury. J Neuroinflammation (2016) 0.78
Cerebrospinal Fluid Cortisol Mediates Brain-Derived Neurotrophic Factor Relationships to Mortality after Severe TBI: A Prospective Cohort Study. Front Mol Neurosci (2017) 0.75
A Rehabilomics framework for personalized and translational rehabilitation research and care for individuals with disabilities: Perspectives and considerations for spinal cord injury. J Spinal Cord Med (2014) 0.75
Neuroprotection by Estrogen and Progesterone in Traumatic Brain Injury and Spinal Cord Injury. Curr Neuropharmacol (2016) 0.75
Assessment of outcome after severe brain damage. Lancet (1975) 27.39
A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study. N Engl J Med (1990) 9.42
Guidelines for the management of severe traumatic brain injury. J Neurotrauma (2007) 4.10
Methylprednisolone or naloxone treatment after acute spinal cord injury: 1-year follow-up data. Results of the second National Acute Spinal Cord Injury Study. J Neurosurg (1992) 3.52
The effects of stress and stress hormones on human cognition: Implications for the field of brain and cognition. Brain Cogn (2007) 3.18
The acute effects of corticosteroids on cognition: integration of animal and human model studies. Brain Res Brain Res Rev (1997) 2.88
Disability rating scale for severe head trauma: coma to community. Arch Phys Med Rehabil (1982) 2.86
ProTECT: a randomized clinical trial of progesterone for acute traumatic brain injury. Ann Emerg Med (2006) 2.86
The stressed synapse: the impact of stress and glucocorticoids on glutamate transmission. Nat Rev Neurosci (2011) 2.82
The stress system in the human brain in depression and neurodegeneration. Ageing Res Rev (2005) 2.74
Blood-brain barrier active efflux transporters: ATP-binding cassette gene family. NeuroRx (2005) 2.44
P-Glycoprotein, a gatekeeper in the blood-brain barrier. Adv Drug Deliv Rev (1999) 2.34
Improved outcomes from the administration of progesterone for patients with acute severe traumatic brain injury: a randomized controlled trial. Crit Care (2008) 2.33
Progesterone receptors: form and function in brain. Front Neuroendocrinol (2008) 2.15
Molecular determinants of glucocorticoid receptor function and tissue sensitivity to glucocorticoids. Endocr Rev (1996) 2.11
Glucocorticoids potentiate ischemic injury to neurons: therapeutic implications. Science (1985) 1.91
Glucocorticoid effects on memory function over the human life span. Dev Psychopathol (2001) 1.83
Prior stressor exposure sensitizes LPS-induced cytokine production. Brain Behav Immun (2002) 1.82
Glucocorticoid therapy alters hormonal and cytokine responses to endotoxin in man. J Immunol (1993) 1.73
Hormones and the stressed brain. Ann N Y Acad Sci (2004) 1.68
The stressed CNS: when glucocorticoids aggravate inflammation. Neuron (2009) 1.66
Pharmacology of traumatic brain injury: where is the "golden bullet"? Mol Med (2008) 1.63
11β-hydroxysteroid dehydrogenases: intracellular gate-keepers of tissue glucocorticoid action. Physiol Rev (2013) 1.60
Use of dexamethasone in the treatment of cerebral edema resulting from brain tumors and brain surgery. Am Pract Dig Treat (1961) 1.59
Stress and hippocampal plasticity: implications for the pathophysiology of affective disorders. Hum Psychopharmacol (2001) 1.58
Allopregnanolone and progesterone decrease cell death and cognitive deficits after a contusion of the rat pre-frontal cortex. Neuroscience (2004) 1.55
Rapid modulation of P-glycoprotein-mediated transport at the blood-brain barrier by tumor necrosis factor-alpha and lipopolysaccharide. Mol Pharmacol (2005) 1.54
Neurosteroids: beginning of the story. Int Rev Neurobiol (2001) 1.52
Neurosteroid biosynthesis: genes for adrenal steroidogenic enzymes are expressed in the brain. Brain Res (1993) 1.49
Septic shock and sepsis: a comparison of total and free plasma cortisol levels. J Clin Endocrinol Metab (2005) 1.43
Transport of steroid hormones through the rat blood-brain barrier. Primary role of albumin-bound hormone. J Clin Invest (1979) 1.42
Gender influences outcome of brain injury: progesterone plays a protective role. Brain Res (1993) 1.42
Penetration of endogenous steroid hormones corticosterone, cortisol, aldosterone and progesterone into the brain is enhanced in mice deficient for both mdr1a and mdr1b P-glycoproteins. J Neuroendocrinol (2002) 1.41
Novel glucocorticoid effects on acute inflammation in the CNS. J Neurochem (2003) 1.33
Multidrug resistance P-glycoprotein hampers the access of cortisol but not of corticosterone to mouse and human brain. Endocrinology (2001) 1.32
Progesterone in the clinical treatment of acute traumatic brain injury. Expert Opin Investig Drugs (2010) 1.32
Allopregnanolone, a progesterone metabolite, enhances behavioral recovery and decreases neuronal loss after traumatic brain injury. Restor Neurol Neurosci (2004) 1.26
Clinical elements that predict outcome after traumatic brain injury: a prospective multicenter recursive partitioning (decision-tree) analysis. J Neurotrauma (2005) 1.24
Corticosteroids for acute traumatic brain injury. Cochrane Database Syst Rev (2005) 1.19
Progesterone as a neuroprotective factor in traumatic and ischemic brain injury. Prog Brain Res (2009) 1.16
An essential component in steroid synthesis, the steroidogenic acute regulatory protein, is expressed in discrete regions of the brain. J Neurosci (2002) 1.15
11β-hydroxysteroid dehydrogenases and the brain: from zero to hero, a decade of progress. Front Neuroendocrinol (2010) 1.13
Progesterone in the treatment of acute traumatic brain injury: a clinical perspective and update. Neuroscience (2011) 1.11
Unbound drug concentration in brain homogenate and cerebral spinal fluid at steady state as a surrogate for unbound concentration in brain interstitial fluid. Drug Metab Dispos (2008) 1.09
Neurosteroid biosynthesis in the human brain and its clinical implications. Ann N Y Acad Sci (2003) 1.09
Expression of 11beta-hydroxylase and aldosterone synthase genes in the rat brain. J Mol Endocrinol (2000) 1.09
Acute serum hormone levels: characterization and prognosis after severe traumatic brain injury. J Neurotrauma (2011) 1.07
Progesterone treatment attenuates brain edema following contusion injury in male and female rats. Restor Neurol Neurosci (1992) 1.06
Higher levels of basal serial CSF cortisol in combat veterans with posttraumatic stress disorder. Am J Psychiatry (2005) 1.05
Metabolite profiling of Alzheimer's disease cerebrospinal fluid. PLoS One (2012) 1.04
Cortisol is transported by the multidrug resistance gene product P-glycoprotein. Br J Cancer (1993) 1.03
Evaluation of cerebrospinal fluid concentration and plasma free concentration as a surrogate measurement for brain free concentration. Drug Metab Dispos (2006) 1.00
Steroid synthesis and metabolism in the nervous system: trophic and protective effects. J Neurocytol (2001) 1.00
Steroidogenic enzyme gene expression in the human brain. Mol Cell Endocrinol (2002) 0.99
Cortisol levels in cerebrospinal fluid correlate with severity and bacterial origin of meningitis. Crit Care (2007) 0.99
The citicoline brain injury treatment (COBRIT) trial: design and methods. J Neurotrauma (2009) 0.97
Messenger RNAs encoding steroidogenic enzymes are expressed in rodent brain. Brain Res Mol Brain Res (1995) 0.97
Value of free cortisol measurement in systemic infection. Horm Metab Res (2007) 0.96
Progesterone synthesis in the nervous system: implications for myelination and myelin repair. Front Neurosci (2012) 0.95
Involvement of IL-1beta in acute stress-induced worsening of cerebral ischaemia in rats. Eur Neuropsychopharmacol (2007) 0.95
Group-based trajectory analysis applications for prognostic biomarker model development in severe TBI: a practical example. J Neurotrauma (2013) 0.94
Rehabilitation outcomes in cognitively impaired patients admitted to skilled nursing facilities from the community. Arch Phys Med Rehabil (2004) 0.94
CSF as a surrogate for assessing CNS exposure: an industrial perspective. Curr Drug Metab (2008) 0.94
Neurosteroids' effects and mechanisms for social, cognitive, emotional, and physical functions. Psychoneuroendocrinology (2009) 0.94
A critical overview of the influence of inflammation and infection on P-glycoprotein expression and activity in the brain. Expert Opin Drug Metab Toxicol (2008) 0.93
S100b as a prognostic biomarker in outcome prediction for patients with severe traumatic brain injury. J Neurotrauma (2013) 0.92
Is progesterone a worthy candidate as a novel therapy for traumatic brain injury? Dialogues Clin Neurosci (2011) 0.91
Cortisol dynamics following acute severe brain injury. Intensive Care Med (2004) 0.90
Glucocorticoid signaling in myeloid cells worsens acute CNS injury and inflammation. J Neurosci (2013) 0.89
Distribution of membrane progesterone receptor alpha in the male mouse and rat brain and its regulation after traumatic brain injury. Neuroscience (2012) 0.85
Impact of aromatase genetic variation on hormone levels and global outcome after severe TBI. J Neurotrauma (2013) 0.85
Disability, physical health and mental health 1 year after traumatic brain injury. Disabil Rehabil (2010) 0.84
Impact of neuropathic pain on the gene expression and activity of cytochrome P450side-chain-cleavage in sensory neural networks. Cell Mol Life Sci (2004) 0.83
Corticosteroid use in the intensive care unit: a survey of intensivists. Can J Anaesth (2013) 0.83
P-glycoprotein-170 inhibition significantly reduces cortisol and ciclosporin efflux from human intestinal epithelial cells and T lymphocytes. Aliment Pharmacol Ther (2002) 0.81
3beta-Hydroxysteroid dehydrogenase/5-ene-4-ene isomerase mRNA expression in rat brain: effect of pseudopregnancy and traumatic brain injury. J Steroid Biochem Mol Biol (2007) 0.80
Therapeutic effects of progesterone and its metabolites in traumatic brain injury may involve non-classical signaling mechanisms. Front Neurosci (2013) 0.79
Advances in neurosteroids: role in clinical practice. Climacteric (2013) 0.79
Cortisol is increased in postmortem cerebrospinal fluid of multiple sclerosis patients: relationship with cytokines and sepsis. Mult Scler (2002) 0.78
Midazolam provides cytoprotective effect during corticosterone-induced damages in rat astrocytes by stimulating steroidogenesis. Neurosci Lett (2013) 0.78
CSF cortisol in patients with depression, mania, or anorexia nervosa and in normal subjects. Am J Psychiatry (1983) 0.78
IL-1β associations with posttraumatic epilepsy development: a genetics and biomarker cohort study. Epilepsia (2014) 2.59
Effect of hyperventilation on extracellular concentrations of glutamate, lactate, pyruvate, and local cerebral blood flow in patients with severe traumatic brain injury. Crit Care Med (2002) 2.21
Neurostimulation for traumatic brain injury. J Neurosurg (2014) 2.10
Timing of hormone therapy, type of menopause, and coronary disease in women: data from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation. Menopause (2011) 2.06
Cognitive impairment associated with adjuvant therapy in breast cancer. Psychooncology (2006) 2.06
Memory impairments with adjuvant anastrozole versus tamoxifen in women with early-stage breast cancer. Menopause (2007) 2.04
Serotonin 1A receptor reductions in postpartum depression: a positron emission tomography study. Fertil Steril (2007) 1.82
Blast exposure in rats with body shielding is characterized primarily by diffuse axonal injury. J Neurotrauma (2011) 1.71
Hormone replacement therapy formulations and risk of epithelial ovarian carcinoma. Gynecol Oncol (2002) 1.60
Persistent cognitive dysfunction after traumatic brain injury: A dopamine hypothesis. Neurosci Biobehav Rev (2009) 1.57
Determination of menopausal status in women: the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) Study. J Womens Health (Larchmt) (2004) 1.57
Polynitroxylated pegylated hemoglobin: a novel neuroprotective hemoglobin for acute volume-limited fluid resuscitation after combined traumatic brain injury and hemorrhagic hypotension in mice. Crit Care Med (2011) 1.54
Survival without brain damage after clinical death of 60-120 mins in dogs using suspended animation by profound hypothermia. Crit Care Med (2003) 1.52
Pulsatile luteinizing hormone amplitude and progesterone metabolite excretion are reduced in obese women. J Clin Endocrinol Metab (2007) 1.50
Attenuation of working memory and spatial acquisition deficits after a delayed and chronic bromocriptine treatment regimen in rats subjected to traumatic brain injury by controlled cortical impact. J Neurotrauma (2002) 1.47
Alterations in gene expression in response to compression of nucleus pulposus cells. Spine J (2010) 1.46
Does lifetime exposure to hormones predict pretreatment cognitive function in women before adjuvant therapy for breast cancer? Menopause (2013) 1.46
Hypoestrogenemia of hypothalamic origin and coronary artery disease in premenopausal women: a report from the NHLBI-sponsored WISE study. J Am Coll Cardiol (2003) 1.44
Concussion in sports: postconcussive activity levels, symptoms, and neurocognitive performance. J Athl Train (2008) 1.38
Adenosine A1 receptor knockout mice develop lethal status epilepticus after experimental traumatic brain injury. J Cereb Blood Flow Metab (2006) 1.37
Biomarkers of primary and evolving damage in traumatic and ischemic brain injury: diagnosis, prognosis, probing mechanisms, and therapeutic decision making. Curr Opin Crit Care (2008) 1.34
Autophagy is increased after traumatic brain injury in mice and is partially inhibited by the antioxidant gamma-glutamylcysteinyl ethyl ester. J Cereb Blood Flow Metab (2007) 1.33
Neuroprotective, neuroplastic, and neurobehavioral effects of daily treatment with levetiracetam in experimental traumatic brain injury. Neurorehabil Neural Repair (2013) 1.30
Acute treatment with the 5-HT(1A) receptor agonist 8-OH-DPAT and chronic environmental enrichment confer neurobehavioral benefit after experimental brain trauma. Behav Brain Res (2006) 1.29
Medial prefrontal cortex 5-HT(2A) density is correlated with amygdala reactivity, response habituation, and functional coupling. Cereb Cortex (2009) 1.26
Experimental model of pediatric asphyxial cardiopulmonary arrest in rats. Pediatr Crit Care Med (2004) 1.24
Evaluation of estrous cycle stage and gender on behavioral outcome after experimental traumatic brain injury. Brain Res (2004) 1.24
Synergism between psychosocial and metabolic stressors: impact on reproductive function in cynomolgus monkeys. Am J Physiol Endocrinol Metab (2007) 1.23
Bromocriptine reduces lipid peroxidation and enhances spatial learning and hippocampal neuron survival in a rodent model of focal brain trauma. J Neurotrauma (2004) 1.19
Comparison of seven anesthetic agents on outcome after experimental traumatic brain injury in adult, male rats. J Neurotrauma (2006) 1.16
The therapeutic efficacy conferred by the 5-HT(1A) receptor agonist 8-Hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) after experimental traumatic brain injury is not mediated by concomitant hypothermia. J Neurotrauma (2004) 1.15
Mitogen-activated protein kinase inhibition in traumatic brain injury: in vitro and in vivo effects. J Cereb Blood Flow Metab (2002) 1.15
Intervention with environmental enrichment after experimental brain trauma enhances cognitive recovery in male but not female rats. Neurosci Lett (2002) 1.13
The high affinity peripheral benzodiazepine receptor ligand DAA1106 binds specifically to microglia in a rat model of traumatic brain injury: implications for PET imaging. Exp Neurol (2007) 1.12
Isoflurane exerts neuroprotective actions at or near the time of severe traumatic brain injury. Brain Res (2006) 1.12
Maternal recall of hypertensive disorders in pregnancy: a systematic review. J Womens Health (Larchmt) (2012) 1.11
Changes in expression of amyloid precursor protein and interleukin-1beta after experimental traumatic brain injury in rats. J Neurotrauma (2002) 1.11
Resveratrol attenuates behavioral impairments and reduces cortical and hippocampal loss in a rat controlled cortical impact model of traumatic brain injury. J Neurotrauma (2010) 1.10
Acute serum hormone levels: characterization and prognosis after severe traumatic brain injury. J Neurotrauma (2011) 1.07
Local administration of the poly(ADP-ribose) polymerase inhibitor INO-1001 prevents NAD+ depletion and improves water maze performance after traumatic brain injury in mice. J Neurotrauma (2007) 1.07
A dual role for poly-ADP-ribosylation in spatial memory acquisition after traumatic brain injury in mice involving NAD+ depletion and ribosylation of 14-3-3gamma. J Neurochem (2003) 1.07
Immunohistochemical analysis of histone H3 acetylation and methylation--evidence for altered epigenetic signaling following traumatic brain injury in immature rats. Brain Res (2006) 1.06
Differential effects of single versus multiple administrations of haloperidol and risperidone on functional outcome after experimental brain trauma. Crit Care Med (2007) 1.05
Protective effects of the 5-HT1A receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin against traumatic brain injury-induced cognitive deficits and neuropathology in adult male rats. Neurosci Lett (2002) 1.04
Salivary cortisol reflects serum cortisol: analysis of circadian profiles. Ann Clin Biochem (2007) 1.03
Delayed increase of tyrosine hydroxylase expression in rat nigrostriatal system after traumatic brain injury. Brain Res (2006) 1.03
Hemorrhagic shock after experimental traumatic brain injury in mice: effect on neuronal death. J Neurotrauma (2009) 1.03
Simvastatin therapy prevents brain trauma-induced increases in beta-amyloid peptide levels. Ann Neurol (2009) 1.03
Menstrual cycle differences between women with type 1 diabetes and women without diabetes. Diabetes Care (2003) 1.02
Chronic Inflammation After Severe Traumatic Brain Injury: Characterization and Associations With Outcome at 6 and 12 Months Postinjury. J Head Trauma Rehabil (2015) 1.01
Transdermal estradiol for postpartum depression: a promising treatment option. Clin Obstet Gynecol (2009) 1.01
Short fetal leukocyte telomere length and preterm prelabor rupture of the membranes. PLoS One (2012) 1.01
Time dependent alterations in dopamine tissue levels and metabolism after experimental traumatic brain injury in rats. Neurosci Lett (2004) 1.00
Total estrogen time and obstructive coronary disease in women: insights from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE). J Womens Health (Larchmt) (2009) 1.00
Sensitivity to stress-induced reproductive dysfunction linked to activity of the serotonin system. Fertil Steril (2005) 1.00
Resuscitation of traumatic brain injury and hemorrhagic shock with polynitroxylated albumin, hextend, hypertonic saline, and lactated Ringer's: Effects on acute hemodynamics, survival, and neuronal death in mice. J Neurotrauma (2009) 1.00
Gender and environmental enrichment impact dopamine transporter expression after experimental traumatic brain injury. Exp Neurol (2005) 0.99
Screening of biochemical and molecular mechanisms of secondary injury and repair in the brain after experimental blast-induced traumatic brain injury in rats. J Neurotrauma (2013) 0.99
Cerebral blood flow at one year after controlled cortical impact in rats: assessment by magnetic resonance imaging. J Neurotrauma (2002) 0.99
Social subordination and polymorphisms in the gene encoding the serotonin transporter enhance estradiol inhibition of luteinizing hormone secretion in female rhesus monkeys. Biol Reprod (2009) 0.98
Traumatic brain injury reduces dopamine transporter protein expression in the rat frontal cortex. Neuroreport (2002) 0.98
Gender associations with chronic methylphenidate treatment and behavioral performance following experimental traumatic brain injury. Behav Brain Res (2007) 0.98
Acute systemic administration of interleukin-10 suppresses the beneficial effects of moderate hypothermia following traumatic brain injury in rats. Brain Res (2002) 0.98
Chronic methylphenidate treatment enhances striatal dopamine neurotransmission after experimental traumatic brain injury. J Neurochem (2008) 0.97
Neuromuscular and biomechanical characteristics do not vary across the menstrual cycle. Knee Surg Sports Traumatol Arthrosc (2007) 0.97
Moderators of interventions designed to enhance physical and psychological functioning among younger women with early-stage breast cancer. J Clin Oncol (2007) 0.95
Current status of the approach to assisted reproduction. Pediatr Clin North Am (2009) 0.95
Group-based trajectory analysis applications for prognostic biomarker model development in severe TBI: a practical example. J Neurotrauma (2013) 0.94
Trajectory analysis of serum biomarker concentrations facilitates outcome prediction after pediatric traumatic and hypoxemic brain injury. Dev Neurosci (2010) 0.94
Docosahexaenoic acid reduces ER stress and abnormal protein accumulation and improves neuronal function following traumatic brain injury. J Neurosci (2014) 0.93
Relations between endogenous androgens and estrogens in postmenopausal women with suspected ischemic heart disease. J Clin Endocrinol Metab (2008) 0.93
Increased cortisol in the cerebrospinal fluid of women with functional hypothalamic amenorrhea. J Clin Endocrinol Metab (2006) 0.93
YKL-40 expression in traumatic brain injury: an initial analysis. J Neurotrauma (2010) 0.93
Transgenic mice that overexpress the anti-apoptotic Bcl-2 protein have improved histological outcome but unchanged behavioral outcome after traumatic brain injury. Brain Res (2006) 0.92
S100b as a prognostic biomarker in outcome prediction for patients with severe traumatic brain injury. J Neurotrauma (2013) 0.92
boc-Aspartyl(OMe)-fluoromethylketone attenuates mitochondrial release of cytochrome c and delays brain tissue loss after traumatic brain injury in rats. J Cereb Blood Flow Metab (2006) 0.92
BCL2 genotypes: functional and neurobehavioral outcomes after severe traumatic brain injury. J Neurotrauma (2010) 0.91
Biologic and plastic effects of experimental traumatic brain injury treatment paradigms and their relevance to clinical rehabilitation. PM R (2011) 0.91
Examining implicit bias of physicians who care for individuals with spinal cord injury: A pilot study and future directions. J Spinal Cord Med (2014) 0.91
Postmenopausal hyperthecosis: functional dysregulation of androgenesis in climacteric ovary. Obstet Gynecol (2002) 0.91
The potential for bio-mediators and biomarkers in pediatric traumatic brain injury and neurocritical care. Front Neurol (2013) 0.91
Gel-based hippocampal proteomic analysis 2 weeks following traumatic brain injury to immature rats using controlled cortical impact. Dev Neurosci (2006) 0.90
Expression of protein phosphatase 2B (calcineurin) subunit A isoforms in rat hippocampus after traumatic brain injury. J Neurotrauma (2010) 0.90
Disruption of Bax protein prevents neuronal cell death but produces cognitive impairment in mice following traumatic brain injury. J Neurotrauma (2008) 0.90
Traumatic brain injury reduces striatal tyrosine hydroxylase activity and potassium-evoked dopamine release in rats. Brain Res (2010) 0.90
Administration of adenosine receptor agonists or antagonists after controlled cortical impact in mice: effects on function and histopathology. Brain Res (2002) 0.89
Morris water maze function and histologic characterization of two age-at-injury experimental models of controlled cortical impact in the immature rat. Childs Nerv Syst (2012) 0.89
Evolution of medical treatment for endometriosis: back to the roots? Hum Reprod Update (2007) 0.89
Severe brief pressure-controlled hemorrhagic shock after traumatic brain injury exacerbates functional deficits and long-term neuropathological damage in mice. J Neurotrauma (2012) 0.89
A novel multicenter preclinical drug screening and biomarker consortium for experimental traumatic brain injury: operation brain trauma therapy. J Trauma (2011) 0.89
Hemorrhagic shock shifts the serum cytokine profile from pro- to anti-inflammatory after experimental traumatic brain injury in mice. J Neurotrauma (2014) 0.89